Co-chaperoning by amyloid-forming proteins: cystatins vs. crystallins

被引:3
|
作者
Zerovnik, Eva [1 ,2 ,3 ]
机构
[1] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, Ljubljana 1000, Slovenia
[2] Jozef Stefan Int Postgrad Sch, Jamova 39, Ljubljana 1000, Slovenia
[3] CipKeBip Ctr Excellence Integrated Approaches Che, Jamova 39, Ljubljana 1000, Slovenia
关键词
Small heat shock proteins; A-beta binding proteins; Amyloid; Protein misfolding; Chaperones; Cystatins; Crystallins; ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; BETA-PROTEIN; STEFIN-B; HUMAN BRAIN; IN-VITRO; BINDING; TOXICITY; FIBRILS;
D O I
10.1007/s00249-017-1214-x
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cystatins and crystallins are both neuroprotective proteins. Except for their function as cysteine cathepsins inhibitors, cystatins are A beta binding proteins and presumably protect neurons from intracellular A beta and extracellular A beta plaques. Pathological mutations of cystatin C cause amyloid angiopathy. Crystallins, known as small heat shock proteins, bind not only A beta peptide but also other crystallins in the eye lens and prevent their aggregation. Mutations in crystallins cause cataracts and myopathies. Cross-interactions between amyloidogenic proteins, intrinsically disordered and folded proteins, can also occur. I term the nonspecific binding between amyloidogenic proteins and peptides "co-chaperoning." A wide range of other A beta binding proteins exist, such as catalase, lysozyme, beta-lactoglobulin and some other abundant proteins found in plasma.
引用
收藏
页码:789 / 793
页数:5
相关论文
共 27 条
  • [21] Competing Interactions between Viral RHIM Amyloid-forming Proteins and Host Functional Amyloid Structures Modulate the Cellular Response to Infection
    Sunder, Margaret
    Pham, Chi L. L.
    Shanmugam, Nirukshan
    Baker, Max O. D. G.
    Steain, Megan
    O'Carroll, Ailis
    Brown, James W.
    Sierecki, Emma
    Gambin, Yann
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 180A - 181A
  • [22] Improved methods for co-evolving the affinity and stability of antibody fragments specific for amyloid-forming polypeptides
    Tiller, Kathryn
    Julian, Mark
    Lee, Christine
    Rabia, Lilia
    Young, James
    Tessier, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [23] Membrane Disruption and Peptide/Lipid Co-Assembly by the Amyloid-Forming Peptide, PAP248-286
    Vane, Eleanor W.
    Nath, Abhinav
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 381A - 382A
  • [24] Viroporins vs. Other Pore-Forming Proteins: What Lessons Can We Take?
    Zerovnik, Eva
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [25] Rare-variant collapsing and bioinformatic analyses for different types of cardiac arrhythmias in the UK Biobank reveal novel susceptibility loci and candidate amyloid-forming proteins
    Zoller, Bengt
    Manderstedt, Eric
    Lind-Hallden, Christina
    Hallden, Christer
    CARDIOVASCULAR DIGITAL HEALTH JOURNAL, 2024, 5 (01): : 15 - 18
  • [26] Expression patterns of DHBV receptor/co-receptor proteins in viral susceptible vs. non-susceptible hepatocytes.
    Lee, HB
    Tong, SP
    Spangenberg, HC
    Wands, JR
    Li, JS
    HEPATOLOGY, 2000, 32 (04) : 380A - 380A
  • [27] Efficient and scalable profiling of an average of 1779 plasma proteins in 268 subjects with multi-nanoparticle (NP) Proteograph platform enables robust detection of early-stage non-small cell lung cancer (NSCLC) and classification vs. healthy and co-morbid subjects
    Blume, John E.
    Manning, William C.
    Troiano, Gregory
    Siddiqui, Asim
    Ma, Philip
    Langer, Robert
    Farias, Vivek
    Farokhzad, Omid C.
    CANCER RESEARCH, 2020, 80 (16)